Century Therapeutics iPSC-derived Allogeneic Cell Therapies for Cancer

Time: 2:10 pm
day: Day Two

Details:

  • Century iPSC-derived iNK cell platform; harnessing the power of induced
    pluripotent stem cells to develop novel allogeneic NK cell therapies for cancer
  • iPSC precise engineering to enable the design of allogeneic NK cells that can
    persist and safely and effectively mediate anti-tumor immunity
  • CAR design strategies that address disease-specific challenges
  • Making highly pure clinical candidate products derived from single iPSC cells
    engineered

Speakers: